ENGAGe and ESGO Present First World Gynecologic Oncology Day

ENGAGe and ESGO Present First World Gynecologic Oncology Day
On Sept. 20, the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe) and the European Society of Gynaecological Oncology (ESGO) presented the first World Gynecologic Oncology Day (World GO Day). Spearheaded by ENGAGe, the initiative, set to occur annually, aims to promote collaboration among patient groups, strengthen local advocacy activities, and provide an engagement platform. The campaign is called “GO for Awareness, Action, Hope, Life.” The main objective is to raise awareness of the impact ovarian and other gynecological cancers have on patients and caregivers, and of unmet needs in disease management. Another goal is to mobilize stakeholders to advocate for better outcomes through early diagnoses, family risk factors, and a holistic approach to patient care. Last year, 1.3 million women globally were diagnosed with such cancers, including cervical, uterine, vaginal, and vulvar in addition to ovarian. Each year, gynecological cancers affect some 71,500 women in the United States alone. “Ovarian, uterine, cervix, and other gynecological cancers are among the most common cancers affecting women, but collectively attract less attention than they deserve from the public and policymakers,” states the World GO Day website. “Women themselves may be unaware of the sometimes-vague symptoms, or may be too embarrassed to consult a doctor, and there remains a stigma associated with these diagnoses in some quarters. This reticence needs to be overcome and a more positive message developed to improve the prevention, screening, treatment and care of gynecological cancers," the website states. This year, roughly 22,530 women in the United States will be diagnosed with ovarian cancer, most of them high-grade serous cancers (HGSC). Ovarian
Subscribe or to access all post and page content.